Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels than healthy people.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Some supplements may help with hair loss, but there's not enough strong evidence to recommend them without doctor advice.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Researchers improved a skin disease diagnosis model using online images, achieving up to 49.64% accuracy.

The new method improves facial image restoration quality and face recognition accuracy.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

Future hair cosmetics will be safer and more effective.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.